Lymphocyte to C-reactive protein ratio could better predict the prognosis of patients with stage IV cancer

BACKGROUND: Systemic inflammation is currently regarded as a hallmark of cancer. This study aimed to accurately clarify the prognostic value of various inflammatory markers in patients with stage IV cancer. METHODS: This study assessed 2,424 patients with cancer diagnosed with cancer in tumor, node,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, He-Yang, Xie, Hai-Lun, Ruan, Guo-Tian, Zhang, Qi, Ge, Yi-Zhong, Liu, Xiao-Yue, Tang, Meng, Song, Meng-Meng, Lin, Shi-Qi, Yang, Ming, Zhang, Xiao-Wei, Xu, Hong-Xia, Song, Chun-Hua, Shi, Han-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585763/
https://www.ncbi.nlm.nih.gov/pubmed/36266627
http://dx.doi.org/10.1186/s12885-022-10145-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585763/
https://www.ncbi.nlm.nih.gov/pubmed/36266627
http://dx.doi.org/10.1186/s12885-022-10145-x

Ejemplares similares